Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate
EPALINGES, SWITZERLAND -- (Marketwired) -- 04/05/16 -- Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome based vaccines to prevent transmission of human infectious diseases, announced today that the …